Aug. 20, 2018 Price forecast | 2 weeks: 5.38% | 1 month: 6.09% | 3 months: 9.28%


EVOK stock forecast

Our latest prediction for Evoke Pharma, Inc.'s stock price was made on the Aug. 20, 2018 when the stock price was at 2.38$.

In the short term (2weeks), EVOK's stock price should outperform the market by 5.38%. During that period the price should oscillate between -7.98% and +14.50%.

In the medium term (3months), EVOK's stock price should outperform the market by 9.28%. During that period the price should oscillate between -18.15% and +33.76%.


About Evoke Pharma, Inc.

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.42$ per share.

The book value per share is 0.32$

Evoke Pharma, Inc. website


Three months stock forecastAug. 20, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -9M - -6M -0.42 - - 16M 0.32 -8M - -8M